You're Doing Everything Right and Still Getting Kidney Stones. Here's Why.

Your kidneys filter your blood constantly, removing waste while hanging onto essential minerals. One of those critical minerals is phosphate. SLC34A1 is the transporter protein that sits in your kidney tubules and decides whether phosphate gets reabsorbed back into your bloodstream or stays in your urine. When working normally, it maintains precise mineral balance and helps keep urine chemistry stable.

Variants in SLC34A1, present in roughly 5 to 10% of the population, reduce how efficiently this transporter works. That means phosphate handling becomes erratic. Your urine phosphate levels fluctuate, changing the mineral saturation and crystal-forming potential of your urine. Even when you’re doing everything right dietarily, your kidneys are creating a chemical environment that favors stone formation.

The day-to-day consequence is recurrent stones, often despite perfect hydration and dietary management. You might notice that standard prevention advice doesn’t touch your actual problem. Stones keep forming because the underlying phosphate imbalance persists.

Your kidneys don’t just filter waste; they also defend themselves. Uromodulin is a protective protein secreted into urine, where it coats your urinary tract lining and defends against infection and crystal formation. It’s like a bodyguard for your kidney tubules. UMOD is the gene that produces it.

Variants in UMOD, found in roughly 10 to 20% of the population, reduce the amount of uromodulin your kidneys secrete. With less protective protein in your urine, your kidneys lose their first line of defense against both infections and stone formation. Your tubules become more vulnerable to crystal nucleation, and the urine environment becomes more stone-prone.

You might experience not just kidney stones but also a higher frequency of urinary tract infections, since the same reduced uromodulin makes you more susceptible to bacterial invasion. Stones seem to form more easily, and you’re fighting both infections and stone recurrence.

Vitamin D doesn’t work directly; your body must convert it into an active hormone form, and then your cells must have functional vitamin D receptors (VDR) to respond. VDR is that receptor. It controls how your kidneys handle calcium, how your intestines absorb minerals, and how your body regulates phosphate. When VDR is working optimally, mineral metabolism stays balanced.

VDR variants, present in a substantial portion of the population, can reduce how efficiently your cells respond to vitamin D signaling. This means your calcium and phosphate handling becomes dysregulated, even if your vitamin D blood levels look normal. You might have adequate vitamin D on paper but functionally deficient signaling at the cellular level, leading to mineral imbalance and stone formation.

You might notice that supplementing vitamin D doesn’t seem to help, or that your calcium levels are unpredictable despite consistent intake. Your urine mineral composition stays chaotic, perpetuating stone formation.

MTHFR is the enzyme that converts folate into its active form, methylfolate, which drives a critical metabolic pathway called methylation. This pathway controls homocysteine levels. Homocysteine is an amino acid that, at elevated levels, damages kidney tubules and endothelial cells, accelerating kidney disease and stone risk.

MTHFR C677T variants, present in roughly 40% of the population, reduce enzyme efficiency by 40 to 70%. When your MTHFR is compromised, homocysteine accumulates because the conversion step that clears it is broken. Elevated homocysteine damages your kidneys directly, making them more vulnerable to stone formation and reducing their ability to maintain mineral balance.

You might have normal kidney function numbers but still experience stone recurrence because the homocysteine damage is subtle and cumulative. Over time, your kidneys’ ability to maintain clean urine chemistry deteriorates, and stones become more frequent.

Oxalate is a molecule your body produces during normal metabolism and also absorbs from foods like spinach, nuts, and chocolate. Your body must convert oxalate into a form it can excrete. AGXT is the enzyme that catalyzes that conversion. When working properly, it ensures oxalate doesn’t accumulate in your urine.

AGXT variants that impair function are rare, but when present, they cause a dramatic buildup of oxalate in urine. This is the condition called primary hyperoxaluria. Even modest oxalate intake can trigger massive crystal formation because your kidneys cannot clear the oxalate load. Calcium oxalate stones become inevitable without aggressive management.

If you have an AGXT variant, you’re essentially fighting a losing battle with any oxalate-containing food. Stones form relentlessly because your metabolism cannot handle normal oxalate levels. Standard diet alone will not prevent recurrence.

Cystine is an amino acid that your kidneys filter and normally reabsorb for reuse. SLC7A9 is the transporter that moves cystine back into your kidney cells. When this transporter works properly, cystine stays out of your urine and your kidneys stay healthy.

Variants in SLC7A9 that impair function are rare but cause cystinuria, a condition where cystine cannot be reabsorbed and accumulates massively in urine. Cystine is poorly soluble, meaning it crystallizes easily and forms stones that are notoriously difficult to break up and prevent. A single SLC7A9 variant carriers face lifelong, recurrent stone formation with limited options.

If you have cystinuria, you’re dealing with a different beast than calcium oxalate stones. Cystine stones are harder to dissolve, recur faster, and require aggressive intervention. You might feel like you’re constantly battling stone formation because, biochemically, you are.